Subscribe to our Newsletters !!
The Biochemical Interdependencies or “Web of Bal
With the MAGIO series, Julabo is expanding its pro
The human metapneumovirus, more simply referred to
We are truly honored to share that HiMedia Laborat
Alembic Pharmaceuticals Limited (Alembic) announce
'Simplicity' seems to be the perfect word to descr
Dear Readers, Welcome to the latest issue of Mi
Biocon has gotten the Establishment Inspection Report (EIR) from the U. S. Food and Drug Administration (FDA) for the Pre-Approval and GMP examination of its Small Molecules API Manufacturing Facility at Biocon Park SEZ, Bommansandra, Bengaluru, led between 20 January and 24 January 2020. At the finish of the review the office had given a Form 483, with five perceptions, which are being tended to by the Company. The EIR has been shut with a VAI arrangement for the perceptions.
